We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Alignment Healthcare (ALHC - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Alignment Healthcare is one of 889 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Alignment Healthcare is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for ALHC's full-year earnings has moved 28.3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, ALHC has moved about 10.9% on a year-to-date basis. In comparison, Medical companies have returned an average of -8.4%. As we can see, Alignment Healthcare is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Amneal Pharmaceuticals (AMRX - Free Report) . The stock has returned 1.1% year-to-date.
For Amneal Pharmaceuticals, the consensus EPS estimate for the current year has increased 4.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Alignment Healthcare belongs to the Medical Services industry, a group that includes 62 individual companies and currently sits at #94 in the Zacks Industry Rank. On average, this group has lost an average of 12% so far this year, meaning that ALHC is performing better in terms of year-to-date returns.
Amneal Pharmaceuticals, however, belongs to the Medical - Drugs industry. Currently, this 133-stock industry is ranked #86. The industry has moved -1.7% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Alignment Healthcare and Amneal Pharmaceuticals as they attempt to continue their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Are Medical Stocks Lagging Alignment Healthcare (ALHC) This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Alignment Healthcare (ALHC - Free Report) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Alignment Healthcare is one of 889 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Alignment Healthcare is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for ALHC's full-year earnings has moved 28.3% higher. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
According to our latest data, ALHC has moved about 10.9% on a year-to-date basis. In comparison, Medical companies have returned an average of -8.4%. As we can see, Alignment Healthcare is performing better than its sector in the calendar year.
Another Medical stock, which has outperformed the sector so far this year, is Amneal Pharmaceuticals (AMRX - Free Report) . The stock has returned 1.1% year-to-date.
For Amneal Pharmaceuticals, the consensus EPS estimate for the current year has increased 4.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Alignment Healthcare belongs to the Medical Services industry, a group that includes 62 individual companies and currently sits at #94 in the Zacks Industry Rank. On average, this group has lost an average of 12% so far this year, meaning that ALHC is performing better in terms of year-to-date returns.
Amneal Pharmaceuticals, however, belongs to the Medical - Drugs industry. Currently, this 133-stock industry is ranked #86. The industry has moved -1.7% so far this year.
Investors interested in the Medical sector may want to keep a close eye on Alignment Healthcare and Amneal Pharmaceuticals as they attempt to continue their solid performance.